Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 14 February, 2020

Goldman Sachs (EPT)

Form 8.5 (EPT/RI)

RNS Number : 0800D
GoldmanSachs International
14 February 2020
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

NMC HEALTH PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

GKSD INVESTMENT HOLDING SA (A COMPANY BACKED BY SPONSORS OF GRUPPO SAN DONATO)

(d) Date dealing undertaken:

13 February 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Purchases

657,107
14,000,000

8.7500 GBP
10.6755 USD

7.6300 GBP
10.6755 USD

10p ordinary

Sales

716,319
14,000,000

8.8080 GBP
10.6755 USD

7.7600 GBP
10.6755 USD

 

 

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

Reducing a long position

1,000

7.7006 GBP

10p ordinary

CFD

Opening a short position

52,006

7.9049 GBP

10p ordinary

CFD

Increasing a short position

309

7.9160 GBP

10p ordinary

CFD

Increasing a short position

591

7.9298 GBP

10p ordinary

CFD

Increasing a short position

29,409

7.9698 GBP

10p ordinary

CFD

Increasing a short position

17,691

7.9698 GBP

10p ordinary

CFD

Reducing a short position

600

7.9954 GBP

10p ordinary

CFD

Increasing a long position

1,000

8.0705 GBP

10p ordinary

CFD

Increasing a short position

9,937

8.0826 GBP

10p ordinary

CFD

Reducing a short position

52,006

8.1090 GBP

10p ordinary

CFD

Reducing a long position

500

8.1367 GBP

10p ordinary

CFD

Reducing a short position

933

8.1820 GBP

10p ordinary

CFD

Reducing a short position

259

8.1820 GBP

10p ordinary

CFD

Reducing a short position

294

8.1820 GBP

10p ordinary

CFD

Reducing a short position

2,272

8.1820 GBP

10p ordinary

CFD

Reducing a short position

17,728

8.1820 GBP

10p ordinary

CFD

Reducing a short position

398

8.1820 GBP

10p ordinary

CFD

Increasing a short position

705

8.3500 GBP

10p ordinary

CFD

Opening a short position

20,000

8.6689 GBP

10p ordinary

CFD

Reducing a short position

611

8.8066 GBP

10p ordinary

CFD

Reducing a short position

1,143

8.8066 GBP

 

 

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date








 

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit






 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)


 

 



 

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

14 February 2020

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected].  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FERBBGDDLDBDGGS

a d v e r t i s e m e n t